Rubin Lab


Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.

Dwadasi S, Zafer M. Goens D, Paknikar R, Dalal S, Cohen RD, Pekow, Rubin DT, Sakuraba A, Micic D. Inflamm Bowel Dis. 2020. [Epub ahead of print December 15 2020.] PMID: 33319248.

The Correlation Between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease.

Yamada A, Yuga K, Komaki F, Haider H, Micic D, Pekow J, Dalal D, Cohen RD, Cannon L, Umanskiy K, Smith R, Shogan BD, Hurst R, Hyman N, Rubin DT, Sakuraba A. Digestion. 2021. [Epub ahead of print February 8 2021]. PMID: 33556932.

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.

D’Amico F, Rubin DT, Kotze P, Magro F, Siegmund B, Kobayashi T, Olivera P, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L. United European Gastroenterol J. 2021. [Epub ahead of print May 7 2021]. PMID: 33961734.

Vedolizumab and Anti-TNFα Real-World Outcomes in Biologic-Naïtop ve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.

Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. J Crohns Colitis. 2021. [Epub ahead of print March 31 2020].

Dissemination of gastroenterology & hepatology research on social media platforms is associated with increased citation count.

Ayoub F, Ouni A, Case R, Ladna M, Shah H, Rubin DT.  Am J Gastroenterol. 2021. [Epub ahead of print March 22 2021]. PMID: 33767107.

Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.

Fendrick A, Brixner D, Rubin DT, Mease P, Liu H, Davis M, Mittal M. J Manag. 2021. [Epub ahead of print April 9, 2021]. PMID: 33843252

Management of code status in the periendoscopic period: a national survey of current practices and beliefs of U.S. Q2 gastroenterologists.

Feld LD, Mergener K, Rubin DT, Rao VL. Gastrointest Endosc. 2021. [Epub ahead of print January 18 2021]. PMID: 33476610.

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ< Sands BE, Walter R, Scholmerich J, Bemelman W, Danese S, Mary JY, Rubin DT, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A. Gastroenterology, 2021;160(5):1570-1583. PMID: 33359090.

Endoscopic phenotype of the J pouch in patients with inflammatory bowel disease: A new classification for pouch outcomes. 

Akiyama S, Ollech JE, Rai V, Glick LR, Yi Y, Traboulsi C, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Clin Gastroenterol Hepatol. 2021. [Epub ahead of print February 4 2021].

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.

Siegel CA, Melmed GY, McGovern DPB, Rai V, Kramer DT, Rubin DT, Abreu MT, Dubinsky MC. Gut. 2021;70(4):635-640. PMID: 33472895.